ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval to Start Phase I/II (I.V.) Clinical Trial
|
|
pageturner
|
35 |
16K |
3 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
35
|
16K
|
3
|
|
ASX - By Stock
|
TSO |
Re:
Ann: Investor Presentation
|
|
pageturner
|
27 |
13K |
0 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
27
|
13K
|
0
|
|
ASX - By Stock
|
TSO |
Re:
Ann: Investor Presentation
|
|
pageturner
|
27 |
13K |
0 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
27
|
13K
|
0
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: Identitii Submits New ISO 20022 IFTI Reports to AUSTRAC
|
|
pageturner
|
33 |
12K |
2 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
33
|
12K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial
|
|
pageturner
|
21 |
6.0K |
2 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
21
|
6.0K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
pageturner
|
125 |
33K |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
125
|
33K
|
1
|
|